Buy Carboprost 250 mcg Injection | PPH Emergency Treatment

Carboprost 250 mcg Injection contains carboprost tromethamine, a prostaglandin F2α analogue used in obstetric emergencies to control severe postpartum hemorrhage (PPH) caused by uterine atony that has not responded to first‑line uterotonic agents such as oxytocin or ergometrine. Carboprost promotes strong uterine contractions that help compress uterine blood vessels and significantly reduce ongoing blood loss.

Key Benefits:

• Rapid Uterine Contraction: Stimulates smooth muscle activity in the uterus to reduce bleeding after childbirth.

• Emergency Support: Recommended in clinical protocols when bleeding is not controlled by standard therapies.

• Single‑Dose Vial: Each vial delivers a precise 250 mcg dose suitable for intramuscular administration.

• Clinically Recognised: Utilised worldwide in maternity care settings and recommended by obstetric guidelines for PPH management.

Mechanism of Action:
Carboprost is a synthetic prostaglandin that directly contracts uterine muscle, facilitating vasoconstriction and hemostasis (suppression of active bleeding). Its action supports the body’s natural processes for uterine involution after delivery.

Indications:

• Postpartum Hemorrhage (PPH): Management of life‑threatening bleeding unresponsive to oxytocin and ergometrine.

• Second‑Trimester Abortion: May also be employed in specific clinical scenarios per practitioner judgement, although primary use is PPH control.

Administration & Dosage:

• Route: Deep intramuscular injection by a licensed healthcare professional.

• Dosage: Typically 250 mcg (0.25 mg) administered intramuscularly. May be repeated every 15–90 minutes as clinically indicated up to a maximum cumulative dose (e.g., 2 mg total).

• Strict aseptic technique and clinical monitoring are required during administration.

Safety & Precautions:

• Prescription Only: Carboprost is a hospital‑use medication and should not be administered outside clinical settings.

• Contraindications: Asthma and other bronchoconstrictive disorders, active cardiac, pulmonary, renal, or hepatic disease require caution or alternative therapy.

• Common Adverse Effects: Nausea, vomiting, diarrhea, fever, flushing, chills, and abdominal cramping are associated with prostaglandin use. Rare severe reactions include bronchospasm and hypersensitivity.

Storage:
Store under manufacturer‑recommended conditions (often refrigerated) and protect from light; discard if vial integrity is compromised.